MindMap Gallery Medicine-General Introduction to Pneumonia
Internal Medicine Respiratory Diseases. Pneumonia is a common respiratory disease caused by infection with pathogenic microorganisms or inhalation of foreign bodies. The main symptoms include cough, sputum production, fever, shortness of breath and difficulty breathing.
Edited at 2023-12-19 10:39:45Discover how Aeon can navigate the competitive online landscape with a strategic SWOT analysis. This comprehensive overview highlights Aeon’s strengths, such as its strong brand recognition, omnichannel capabilities, and customer loyalty programs, alongside its weaknesses, including digital maturity gaps and cost structure challenges. Opportunities for growth include enhancing e-commerce competitiveness and leveraging data-driven strategies, while threats from online-first players and market dynamics require attention. Explore how Aeon can strengthen its market position through innovation and customer-centric approaches in the ever-evolving retail environment.
Discover how Aeon effectively tailors its offerings to meet the diverse needs of family-oriented consumers through a comprehensive Segmentation, Targeting, and Positioning (STP) analysis. Our approach begins with demographic segmentation, examining family life stages, household sizes, income levels, and parent age bands to identify distinct consumer groups. Geographic segmentation highlights store catchment types and community characteristics, while psychographic segmentation delves into family values and lifestyle orientations. Behavioral segmentation focuses on shopping missions, price sensitivity, and channel preferences. Finally, needs-based segmentation reveals core family needs related to value and budget considerations. Join us as we explore these insights to enhance family shopping experiences at Aeon.
Discover the dynamics of sneaker transactions with our Kream Sneaker Consumption Scene Analysis Template. This comprehensive framework aims to visualize the purchasing and consumption journeys of sneakers, identifying key demand drivers and obstacles. It covers user behavior within Kream and external influences, targeting various sneaker categories over specific timeframes and regions. The analysis defines user segments, including collectors, resellers, sneakerheads, casual trend followers, and gift purchasers, each with unique values and KPIs. It outlines the consumption journey from awareness to resale, highlighting critical touchpoints such as search, purchase, inspection, and sharing experiences. Key performance indicators are established to measure engagement and satisfaction throughout the process. Join us in exploring the intricate world of sneaker trading!
Discover how Aeon can navigate the competitive online landscape with a strategic SWOT analysis. This comprehensive overview highlights Aeon’s strengths, such as its strong brand recognition, omnichannel capabilities, and customer loyalty programs, alongside its weaknesses, including digital maturity gaps and cost structure challenges. Opportunities for growth include enhancing e-commerce competitiveness and leveraging data-driven strategies, while threats from online-first players and market dynamics require attention. Explore how Aeon can strengthen its market position through innovation and customer-centric approaches in the ever-evolving retail environment.
Discover how Aeon effectively tailors its offerings to meet the diverse needs of family-oriented consumers through a comprehensive Segmentation, Targeting, and Positioning (STP) analysis. Our approach begins with demographic segmentation, examining family life stages, household sizes, income levels, and parent age bands to identify distinct consumer groups. Geographic segmentation highlights store catchment types and community characteristics, while psychographic segmentation delves into family values and lifestyle orientations. Behavioral segmentation focuses on shopping missions, price sensitivity, and channel preferences. Finally, needs-based segmentation reveals core family needs related to value and budget considerations. Join us as we explore these insights to enhance family shopping experiences at Aeon.
Discover the dynamics of sneaker transactions with our Kream Sneaker Consumption Scene Analysis Template. This comprehensive framework aims to visualize the purchasing and consumption journeys of sneakers, identifying key demand drivers and obstacles. It covers user behavior within Kream and external influences, targeting various sneaker categories over specific timeframes and regions. The analysis defines user segments, including collectors, resellers, sneakerheads, casual trend followers, and gift purchasers, each with unique values and KPIs. It outlines the consumption journey from awareness to resale, highlighting critical touchpoints such as search, purchase, inspection, and sharing experiences. Key performance indicators are established to measure engagement and satisfaction throughout the process. Join us in exploring the intricate world of sneaker trading!
4. General introduction to pneumonia
Causes and mechanisms
1. Normal respiratory immune defense mechanism
(1) The integrity of the intrabronchial mucus-ciliary delivery system, alveolar macrophages and other cellular defenses keeps the respiratory tract below the tracheal carina sterile.
(2) Whether pneumonia occurs depends on two factors: pathogen and host factors.
2. Transmission routes
Community-acquired pneumonia (CAP)
①Air inhalation
②Hematogenous dissemination
③Spread adjacent to the infected site
④Aspiration of upper respiratory tract colonized bacteria
Hospital-acquired pneumonia (HAP)
It can also be caused by aspiration of colonizing bacteria in the gastrointestinal tract (gastroesophageal reflux) and inhalation of pathogenic bacteria in the environment through artificial airways.
Types
1.Anatomical classification
Lobar pneumonia
Streptococcus pneumoniae
Lobular pneumonia
Streptococcus pneumoniae, Staphylococcus aureus, viruses, Mycoplasma pneumoniae, and Legionella
interstitial pneumonia
Bacteria, mycoplasma, chlamydia, viruses or Pneumocystis jiroveci, etc.
2.Cause classification
bacterial pneumonia
The most common pathogenic bacteria include Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, etc.
atypical pneumonia
Common ones include Mycoplasma, Chlamydia, Legionella, etc.
viral pneumonia
Coronavirus, adenovirus, respiratory syncytial virus, influenza virus, etc.
fungal pneumonia
Candida, Aspergillus, Cryptococcus, Pneumocystis, Mucor, etc.
Pneumonia caused by other pathogens
Rickettsia (such as Q fever rickettsia), Toxoplasma (such as Toxoplasma gondii), parasitism (such as pulmonary hydatid, paragonimiasis, pulmonary schistosomiasis), etc.
pneumonia caused by specific factors
Radiation pneumonitis caused by radiation damage, chemical pneumonitis caused by gastric acid inhalation, lipoid pneumonia caused by inflammatory response to inhaled or endogenous lipid substances, etc.
3. Classification of disease environment
Community-acquired pneumonia (CAP)
It refers to infectious lung parenchymal inflammation suffered outside the hospital, including pneumonia caused by pathogenic infection with a clear incubation period and onset within the average incubation period after admission.
Pathogenic bacteria
Common pathogens are Streptococcus pneumoniae, Mycoplasma, Chlamydia, Haemophilus influenzae and respiratory viruses (influenza A and B viruses, adenovirus, respiratory syncytial virus and parainfluenza virus), etc.
Teacher Zhaozhao's shorthand: "community", "branch", "original", "ball" team, "clothes" to prevent "cold" and "virus"
in accordance with
① Newly developed cough and sputum, or aggravation of original respiratory disease symptoms and the appearance of purulent sputum, with or without chest pain
②Fever
③Signs of lung consolidation and/or wet rales
④WBC>10×10^9/L or <4×10^9/L, with or without left shift of neutrophil nuclei; chest X-ray examination shows patchy, patchy infiltrative shadows or interstitial changes, With or without pleural effusion
Hospital-acquired pneumonia (HAP)
It refers to pneumonia that does not exist when the patient is admitted, nor is it in the incubation period, but occurs in the hospital 48 hours after admission.
Pathogenic bacteria
Common pathogens are Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, etc. (Except Staphylococcus aureus, which is Gram-positive, the others are negative)
Teacher Zhaozhao's shorthand: "Kreb" and "Big" didn't dare to "move" when they saw the "yellow" and "green" lights. Concerned
According to the same as CAP
Manifestations and signs
symptom
① Cough, expectoration, or original respiratory symptoms worsen, and purulent sputum or bloody sputum appears, with or without chest pain
②Most patients have fever
③Those with large lesions may have difficulty breathing and respiratory distress.
physical signs
① There are no obvious abnormalities in early pulmonary signs; severe cases may have increased respiratory rate, nose flaring, and cyanosis.
② There are typical signs of pulmonary consolidation, such as percussion dullness, increased tremor, and bronchial breath sounds. Wet rales may also be heard; in patients with pleural effusion, percussion dullness in the chest on the affected side, weakened tremor, and weakened breath sounds
laboratory tests
phlegm
① If the concentration of pathogenic bacteria or conditional pathogenic bacteria isolated by quantitative culture is ≥10^7cfu/ml, they can be considered to be the pathogenic bacteria of pulmonary infection.
②≤10^4cfu/ml indicates contaminating bacteria
③If it is between the two, it is recommended to repeat the sputum culture; if the same bacteria are continuously isolated, 10^5~10^6cfu/ml more than two times in a row, it can also be considered a pathogenic bacteria
Suction via fiberoptic bronchoscope or artificial channel
The chance of being contaminated by oropharyngeal bacteria is less than that of expectoration. If the concentration of bacterial culture in the aspirate is ≥10^5cfu/ml, it can be considered to be pathogenic bacteria. If the concentration is lower than this, it is mostly contaminating bacteria.
Anti-contamination sample brush
If bacteria ≥10^3cA/ml, they can be considered pathogenic bacteria
bronchoalveolar lavage
If the bacteria are ≥10^4cfu/ml and the bacteria in the anti-contamination BAL specimen are ≥10^3cfu/ml, they can be considered pathogenic bacteria.
Fine needle aspiration and open lung biopsy
The sensitivity and specificity are very good, but because it is an invasive examination, it can easily cause complications, such as pneumothorax, etc.
urine antigen test
Includes Legionella and Streptococcus pneumoniae urinary antigens
serology test
Specific lgM antibody titers, such as a 4-fold increase in antibody titers between the acute phase and the recovery phase, can be used to diagnose infections such as Mycoplasma, Chlamydia, Legionella pneumophila, and viral infections, which are mostly retrospective diagnoses.
treat
1. Anti-infective treatment
It is a key link in the treatment of pneumonia, including empirical treatment and anti-pathogen treatment.
Population and preferred antibiotics
Young adults and CAP patients without underlying diseases
Penicillins, first-generation cephalosporins
drug-resistant Streptococcus pneumoniae
Respiratory fluoroquinolones (quinolones are contraindicated in pregnant women and those under 18 years of age)
Elderly, pre-existing or hospitalized CAP
Respiratory fluoroquinolones, second- and third-generation cephalosporins, β-lactams/β-lactamase inhibitors or ertapenem, which may be combined with macrolides
HAP
Second and third generation cephalosporins, β-lactams/β-lactamases, fluoroquinolones or carbapenems
2. Severe pneumonia
First of all, broad-spectrum and powerful antibiotics should be selected, and they should be used in sufficient amounts and in combination.
Types and methods of administration
Severe CAP
Beta-lactams combined with macrolides or fluoroquinolones
Penicillin allergy
Respiratory fluoroquinolones and aztreonam
HAP
Any of the antipseudomonal beta-lactams, broad-spectrum penicillins/beta-lactamase inhibitors, carbapenems combined with respiratory fluoroquinolones or aminoglycosides
MDR coccal infection
Combined with vancomycin, teicoplanin, or linezolid
3. Treatment methods
Antibiotic treatment should be carried out as early as possible. Once pneumonia is suspected, the first dose of antibiotics should be given immediately. The earlier the treatment, the better the prognosis. After the condition stabilizes, the intravenous route can be switched to oral treatment.
Deactivation criteria (should all be met)
①Body temperature ≤37.8C;
②Heart rate ≤100 beats/min;
③Respiratory frequency ≤24 times/min
④Blood pressure: systolic blood pressure ≥90mmHg
⑤Sa02≥90% or Pa02≥60mmHg under breathing indoor air conditions;
⑥Able to take food orally;
⑦The mental state is normal.
The course of antibiotic treatment is 7 to 10 days or longer, and 48 to 72 hours if the body temperature is normal. If any of them are not met, continue to use it.
4. Condition assessment
The condition should be evaluated 48 to 72 hours after antibiotic treatment.
If symptoms do not improve after 72 hours, the reasons may be:
①The drug fails to cover the pathogenic bacteria, or the bacteria are resistant
②Special pathogen infection, such as Mycobacterium tuberculosis, fungi, viruses, etc.;
③ Complications occur or there are host factors that affect the efficacy (such as immunosuppression);
④ Non-infectious diseases are misdiagnosed as pneumonia;
⑤ Drug fever.